Navigation Links
Researchers Pinpoint Best Treatment to Reduce Deadly USA300, MRSA Staph Infections
Date:1/23/2008

CORVALLIS, Ore., Jan. 23 /PRNewswire/ -- According to a recent College of Pharmacy study at Oregon State University, one type of over-the-counter product for minor wound care is substantially more effective than others in killing MRSA, including the virulent strain USA300. Scientists conducting the study compared three common over-the-counter wound care treatments for effectiveness against four strains of community acquired MRSA. Breaks in the skin, such as cuts and scrapes, are the most common entry point for the highly aggressive staph bacteria.

The new laboratory study showed that standard OTC antibacterial products are helpful for preventing common infections but only one product, Staphaseptic, made by Tec Laboratories, was effective in killing MRSA and the USA300 strain. The ointment-like gel, made with Benzethonium chloride, tea tree oil and white thyme oil, killed MRSA quicker and more effectively than the other compounds tested and had a sustained killing effect for 24 hours.

"We wanted to try these common OTC wound-treating products to see if they would kill a wide range of MRSA strains since MRSA has mutated significantly into more than one strain," said Oregon State's Dr. J. Mark Christensen, one of the authors of the study.

According to information from OSU, scientists there found that each of the products tested had some effectiveness, but only the Staphaseptic product had a genuine "bactericidal" effect -- meaning it reduced the number of bacteria by a factor of 1,000 -- against all four of the tested MRSA strains. The four strains tested were USA300-1, USA300-2, USA300-3, and USA400.

Also included in the testing were products made with neomycin and polymyxin; and another made with polymyxin and gramicidin. All three of the compounds used in the tests are widely available over the counter at national drug store chains. Staphaseptic is relatively new, while the other two are commonly found, with slight variations, in "
'/>"/>

SOURCE Tec Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Researchers develop darkest manmade material
2. Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
3. Researchers use magnetism to target cells to animal arteries
4. Ames Laboratory researchers solve fuel-cell membrane structure conundrum
5. Researchers outline structure of largest nonvirus particle ever crystallized
6. UD researchers race ahead with latest spintronics achievement
7. ASU researchers improve memory devices using nanotech
8. Researchers underscore limitations of genetic ancestry tests
9. Researchers measure carbon nanotube interaction
10. Stevens researchers provide new information about mass spectrometry
11. CU researchers shed light on light-emitting nanodevice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ries have an opportunity to take the lead in two s...niversity of Valencia (UV), working together with ...e fabric of the Spanish biotechnology industry. Th...ors have more clout than those in English-speaking...nd plants has been overlooked by the leading count...
(Date:11/20/2009)... Cell Therapeutics, Inc. ...the Ninth Circuit Court of Appeals reversed a U.S.... allowed to pursue all of its claims against The L...ourt for trial. CTI filed a complaint against The...t consultant for CTI,s product TRISENOX, in 2007 s...
(Date:11/19/2009)...ewswire-FirstCall/ -- Omeros Corporation (Nasdaq: ...s for the third quarter ended September 30, 2009. ...ros reported a net loss of $3.9 million, or $1.34 ...on, or $2.54 per share, for the same period in 200...he Company reported a net loss of $15.5 million, o...
(Date:11/19/2009)...WALTHAM, Mass., Nov. 19 Arlington ...d that the leading driver of antibiotic selection ...m activity against gram-positive and gram-negative...an cause nosocomial pneumonia, surveyed European p...ts that provide appropriate coverage against commo...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
... ) today,announced that its Board of Directors has...enior Vice President, Corporate Affairs effective,..., who has announced her,plans to retire., Prior t...dent,Corporate Affairs at ARAMARK since 2003. Duri...cutive roles for several leading companies. He for...
...gies,Inc. (Amex: PTN ) will announce its second q... period ended December 31, 2007 on February 11,200... The Company will also conduct a teleconference an... management team on February 11, 2008 at which,the...r detail and provide,an update on corporate develo...
...ation,(Nasdaq: DRRX ) announced today financial r...r 31, 2007. Total revenues were $6.6 million for t...to $5.4 million for the same,period in 2006. Net l...as,$7.2 million, compared to a net loss of $9.8 mi...//www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )...
Other Biology Technology:Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs 2Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th 2DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 2DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 3DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 4DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 5DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 6DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 7DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 8DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 9
(Date:11/19/2009)...ing the genetic instructions inside corn, one of t... of the most complex sequences of DNA ever analyze... David Schwartz, who was one of more than 100 auth...The maize genome is a true maze full of confusing... sequencers for years," says Schwartz. , Publica...
(Date:11/19/2009)...in maize, also known as corn, researchers across t...hould pave the way to significant improvements in ...al feed and fiber around the world. , The new ma... map, charts genetic diversity and recombination a...research team, led by U.S. Department of Agricultu...
(Date:11/19/2009)... T. Ming Chu Professor of Biochemistry and Molecul...ng how regulatory proteins control the production ...rking with collaborators including Drs. Mitchell W...ladelphia, they focused specifically on the comple...es). These cells contain large amounts of hemoglob...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 1Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 4661 3Mice run faster on high grade oil 9038 1Mice run faster on high grade oil 9038 2Super sleepers could help super sizers 21 9034 1Super sleepers could help super sizers 21 9034 2
...ons to Identify Individuals for Access to ...s, WALL, N.J., Sept. 22 BIO-key International,In...based biometric,identification and wireless public...ork, is showcasing its fingerprint biometric solut...ing held at the Moscone Center in San,Francisco fr...
... 22, 2008) Researchers at the University of Calga... infections in people with cystic fibrosis (CF). T... National Academy of Science USA, this week. , ...e with CF. Pseudomonas aeruginosa is a common bact...ciated with severe lung infections. Pseudomonas re...
...entists and news organizations typically focus on ...s, but research at the University of Michigan sugg...n large numbers of people are the key to understan...ctious disease: cholera. , Using a model develope...d their collaborators came up with results that ch...
Other Biology News:BIO-key(R) International To Exhibit at Oracle OpenWorld 2BIO-key(R) International To Exhibit at Oracle OpenWorld 3BIO-key(R) International To Exhibit at Oracle OpenWorld 4New approach to treating cystic fibrosis lung infection shows promise 2Hidden infections crucial to understanding, controlling disease outbreaks 2Hidden infections crucial to understanding, controlling disease outbreaks 3
Human HGF, Unconjugated from R&D Systems
Anti-alpha1-Antitrypsin Monoclonal Antibody, Unconjugated from CHEMICON
Senescence Colorimetric Assay Kit from BioVision
Mouse LIGHT / TNFSF14, Unconjugated from R&D Systems
Biology Products: